Showing results (151-160 of 768) with videos related to

Sort By:
Pageof 77
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
IL-17 inhibitors for psoriasisSo Yeon Paek, Jillian Frieder, Dario Kivelevitch, et al.
Journal of the American Academy of Dermatology|April 22, 2008
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologicsAlice Gottlieb, Neil J Korman, Kenneth B Gordon, et al.
Pediatric Health, Medicine and Therapeutics|February 2, 2018
Efficacy and safety of ustekinumab in adolescentsRoselyn Kellen, Nanette B Silverberg, Mark Lebwohl
The Journal of Clinical and Aesthetic Dermatology|April 3, 2012
Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque PsoriasisMark Lebwohl, Norman Preston, Ronald W Gottschalk
Journal of Drugs in Dermatology : JDD|December 27, 2018
Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment StrategyEmil Tanghetti, Mark Lebwohl, Linda Stein Gold
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|September 15, 2006
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized studyNicholas Lowe, Stephen Horwitz, Emil Tanghetti, et al.
Journal of Drugs in Dermatology : JDD|December 31, 2008
Verrucous linear (segmental) psoriasis of the right leg responding to radiation therapyFiona Larsen, Alan Menter, Clay J Cockerell, et al.
Journal of the American Academy of Dermatology|November 13, 2007
Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasisAmy Perlmutter, Jennifer Cather, Billy Franks, et al.
Expert Opinion on Emerging Drugs|November 27, 2013
Emerging topical treatments for psoriasisDario N Kivelevitch, Katherine R Hebeler, Mahir Patel, et al.
Clinical Pharmacology and Therapeutics|September 30, 2017
Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory ConditionsJillian Frieder, Dario Kivelevitch, Isabel Haugh, et al.
Pageof 77